Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

From Shkreli biographical timeline

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
apostrophe Member Profile
 
Followed By 19
Posts 1,084
Boards Moderated 0
Alias Born 10/17/06
160x600 placeholder
BTIG Remains a Buy on Anavex Life Sciences (AVXL) TipRanks - 1/19/2022 1:45:28 AM
Anavex Life Sciences (AVXL) Gets a Buy Rating from H.C. Wainwright TipRanks - 1/11/2022 6:45:12 AM
JonesTrading Reaffirms Their Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/10/2022 12:55:34 PM
Anavex Life Sciences Reports Positive Results from Phase 1 Clinical Trial of ANAVEX®3-71 GlobeNewswire Inc. - 1/10/2022 7:00:00 AM
Anavex Life Sciences Promotes Walter E Kaufmann, M.D. to Chief Scientific Officer and Appoints Edward R Hammond, M.D., M.P.H., Ph.D., as Chief Medical Officer GlobeNewswire Inc. - 1/6/2022 7:00:00 AM
Anavex Life Sciences Updates 2 Key Risk Factors TipRanks - 1/6/2022 6:01:37 AM
Anavex Life Sciences to Present at the H.C. Wainwright Virtual BioConnect 2022 Conference GlobeNewswire Inc. - 1/5/2022 7:00:00 AM
Dawson James Maintains a Buy Rating on Anavex Life Sciences (AVXL) TipRanks - 1/5/2022 4:10:29 AM
Anavex Life Sciences to Present at 40th Annual J.P. Morgan Healthcare Conference GlobeNewswire Inc. - 12/14/2021 7:00:00 AM
Anavex Life Sciences to Present at the 4th Annual Evercore ISI HealthCONx Conference GlobeNewswire Inc. - 11/29/2021 7:00:00 AM
Anavex Life provides key updates on clinical trials in rare genetic neurological disorders Seeking Alpha - 11/24/2021 9:40:36 AM
Anavex Life Sciences EPS misses by $0.39 Seeking Alpha - 11/24/2021 7:07:01 AM
Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results GlobeNewswire Inc. - 11/24/2021 7:00:00 AM
Notable earnings after Wednesday's close Seeking Alpha - 11/23/2021 5:35:23 PM
Anavex Life Sciences FY 2021 Earnings Preview Seeking Alpha - 11/23/2021 1:20:23 PM
Notable earnings before Wednesday's open Seeking Alpha - 11/23/2021 10:42:34 AM
Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wednesday, November 24, 2021 GlobeNewswire Inc. - 11/17/2021 7:00:00 AM
Anavex Life Sciences Announces Participation at Upcoming Lausanne VIII Workshop Panel - Building Global Momentum for Interventions in Alzheimer’s Disease GlobeNewswire Inc. - 11/10/2021 7:00:00 AM
Anavex Life Sciences to Present at the Dawson James Securities 6th Annual Conference GlobeNewswire Inc. - 10/15/2021 7:00:00 AM
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease GlobeNewswire Inc. - 10/13/2021 7:00:00 AM
Cassava down after phase 3 simufilam announcement; other Alzheimer's names follow Seeking Alpha - 10/6/2021 12:51:22 PM
CEO Presenting on the Emerging Growth Conference on September 29  Register Now InvestorsHub NewsWire - 9/28/2021 8:00:00 AM
Anavex Life Sciences Announces Participation at 5th Pharma Pricing, Reimbursement & Market Access 2021 GlobeNewswire Inc. - 9/27/2021 9:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/27/2021 8:11:01 AM
Anavex Life Sciences Announces Uplisting to the NASDAQ Global Select Market® GlobeNewswire Inc. - 9/27/2021 7:00:00 AM
apostrophe   Wednesday, 01/27/16 05:40:53 PM
Re: Minotaur post# 51400
Post # of 347047 
From Shkreli biographical timeline

"2011: In 2011, Shkreli filed requests with the FDA to reject a new cancer diagnostic device from Navidea Biopharmaceuticals and an inhalable insulin therapy from MannKind Corporation while publicly short-selling both companies' stocks, the values of which dropped after Shkreli's interventions."

http://www.bing.com/search?q=martin+shkreli&form=PRUSEN&mkt=en-us&refig=0552fd22c524450b9ee2717275462809&qs=HS&pq=martin&sc=8-6&sp=1&cvid=0552fd22c524450b9ee2717275462809

Like to think otherwise, but it would seem that the SEC is not immune to being used as a tool of market manipulation as per the above.

Was thinking about AVXL not being on the list someone posted of Shkreli related SEC supeona information. Some of us were hoping the SEC was investigating attacks on AVXL stock as being the reason for the supeona requesting information from AVXL.

We probably shouldn't be too surprised if it turns out that some sort of "anonymous tip" was sent to bait the SEC into an obligaory inquiry via supeona of AVXL. Then, that would have provided enough of a pretext for the first "ambulance chaser" to be ushered in. The others piling in, like this latest, are just along for the ride, but, nevertheless, all the insinuation laden announcements have served to suppress the share price by discouraging investment. One could probably indentify several parties that benefit from obstacles being thrown in the company's path, although short sellers would be at the top of the list.

If it turns out that the SEC has been manipulated to spur a negative propaganda campaign, essentially free negative publicity to artificially suppress the share price, then whoever filed the false complaint might held accountable, depending how anonymous they were and whether the SEC would be ticked off at being used in such a manner.

re:"Is it possible to sue these ambulance chasers? "

The announcements, though laden with damaging insinuation, are cunningly worded to preclude that. They are, after all, lawyers. So, probably not, in the sense of it likely being rather futile.

It's the insidious implication of presumed guilt in the ads that cause the most damage to the investor "good will" portion of the company's valuation. Although these firms are oppurtunistic in the manner of proverbial "amulance chasers", it is not necessary for them to issue media pronouncements to solicit potencial class action clients, because they already know who to mail the plaintiff request letters out to, via information held by the shareholders' stock brokers. Since there is a legal precedent for goverment to ban harmful tobacco and alchoholic beverage ads, it could be argued that a certain class of legal services advertising that harms the financial health of the litigation target company, and by extension, cause financial damage to current shareholders in that company, should be similarly banned.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences